Clinical Trials
22 trialsNCT05212246 2026-05-08
B3C
VA Office of Research and Development
Phase 3 Not yet recruiting
NCT07311070 2026-01-06
Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue
Mashhad University of Medical Sciences
Phase 3 Enrolling by invitation
NCT05078047 2025-06-05
MOIO
UNICANCER
Phase 3 Recruiting
NCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT05955924 2025-02-21
SPRINTR
Women's College Hospital
Phase 3 Recruiting
NCT04308395 2024-09-24
Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Sol-Gel Technologies, Ltd.
Phase 3 Terminated
NCT00472043 2024-08-06
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma
Galderma R&D
Phase 3 Completed
NCT00472108 2024-08-05
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma
Galderma R&D
Phase 3 Completed
NCT03703310 2024-07-03
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)
Sol-Gel Technologies, Ltd.
Phase 3 Completed
NCT06150144 2024-01-02
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
University of Aleppo
Phase 3 Unknown
NCT00473343 2023-01-05
Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma
Galderma R&D
Phase 3 Completed
NCT02144077 2022-11-03
Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT00189280 2022-02-22
Aldara for the Treatment of Large and/or Multiple sBCC
Viatris Inc.
Phase 3 Completed
NCT00189241 2022-02-07
A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
Viatris Inc.
Phase 3 Completed
NCT05046262 2021-09-16
Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study
Bispebjerg Hospital
Phase 3 Unknown
NCT00005884 2019-12-13
Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer
University of Wisconsin, Madison
Phase 3 Completed
NCT00066872 2013-09-17
Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01212549 2011-09-02
IMCXvsCIMT
University of Ioannina
Phase 3 Completed
NCT00663650 2011-07-12
Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control
Queen's University
Phase 3 Unknown
NCT00049959 2011-03-16
Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
QLT Inc.
Phase 3 Terminated
NCT00129519 2010-07-16
A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
Graceway Pharmaceuticals, LLC
Phase 3 Completed
NCT00007631 2009-01-30
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
VA Office of Research and Development
Phase 3 Completed